XML 62 R51.htm IDEA: XBRL DOCUMENT
v3.25.3

Financial Instruments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of Derivative Instruments | The Company’s assets and liabilities related to unrealized gains or losses on fair value hedges measured at fair value on September 30, 2025 and December 31, 2024 are as follows:
Derivatives designated as fair value hedges | Balance Sheet Location |  | September 30, 2025 |  | December 31, 2024
Asset (liability) derivatives: |  |  | $’000 |  | $’000
Derivative contracts | Other current liabilities |  | — |  |  | (60) |
Total |  |  | — |  |  | (60) |
The table below summarizes the realized gain or (loss) on the Company’s derivative instruments that are designated as fair value hedges and their location in the Unaudited Condensed Consolidated Statement of Operations and Other Comprehensive Income / (Loss):
|  |  | Three Months Ended September 30,
Derivatives in hedging relationships | Location of Gain / (Loss) Recognized |  | 2025 |  | 2024
|  |  | $’000 |  | $’000
Derivative contracts | Cost of goods sold |  | — |  |  | 5,461 |
Total |  |  | — |  |  | 5,461 |
|  |  | Nine Months Ended September 30,
Derivatives in hedging relationships | Location of Gain / (Loss) Recognized |  | 2025 |  | 2024
|  |  | $’000 |  | $’000
Derivative contracts | Cost of goods sold |  | (31) |  |  | 11,995 |
Total |  |  | (31) |  |  | 11,995 |
The follow table sets forth the fair value of derivatives not designated as hedging instruments as of September 30, 2025 and December 31, 2024:
Derivatives | Balance Sheet Location |  | September 30, 2025 |  | December 31, 2024
Asset (liability) derivatives: |  |  | $’000 |  | $’000
Derivative contracts | Other current assets |  | — |  |  | 18,602 |
Derivative asset | Other current assets |  | — |  |  | 93,520 |
Derivative liability | Other current liabilities |  | — |  |  | (92,094) |
Total |  |  | — |  |  | 20,028 |
The table below summarizes the realized g ain or (loss) on the Company’s derivative instruments that are not designated as hedges and their location in the Unaudited Condensed Consolidated Statement of Operations and Other Comprehensive Income / (Loss):
|  |  | Three Months Ended September 30,
Derivatives | Location of Gain / (Loss) Recognized |  | 2025 |  | 2024
|  |  | $’000 |  | $’000
Derivative contracts | Cost of goods sold |  | — |  |  | (1,718) |
Total |  |  | — |  |  | (1,718) |
|  |  | Nine Months Ended September 30,
Derivatives | Location of Gain / (Loss) Recognized |  | 2025 |  | 2024
|  |  | $’000 |  | $’000
Derivative contracts | Cost of goods sold |  | (18,633) |  |  | (2,969) |
Total |  |  | (18,633) |  |  | (2,969) |

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item. + References No definition available. + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration